mast cell leukemia (MCL)
Showing 9976 - 10000 of >10,000
Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)
Recruiting
- Nonsquamous Non-Small Cell Lung Cancer
- Sintilimab
- +3 more
-
Yichang, Hubei, ChinaDepartment of Medical Oncology, Central Hospital of Yichang City
Nov 5, 2021
Peripheral T-cell Lymphoma Trial in Shanghai (BEAC, Cladribine combined with BEAC)
Recruiting
- Peripheral T-cell Lymphoma
- BEAC
- Cladribine combined with BEAC
-
Shanghai, Shanghai, ChinaRuijin Hospital
May 9, 2021
GVHD Trial run by the NHLBI (Topical Dexamethasone, Placebo)
Completed
- Graft vs Host Disease
- Topical Dexamethasone
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022
Lymphoma, Mantle-Cell Trial (Tositumomab and Iodine I 131 Tositumomab followed by CHOP)
Completed
- Lymphoma, Mantle-Cell
- Tositumomab and Iodine I 131 Tositumomab followed by CHOP
- (no location specified)
Nov 19, 2019
Breast-implant ASsocIated anaplastIc Large Cell Lymphoma and
Recruiting
- Breast Implant-Associated Anaplastic Large Cell Lymphoma
- +2 more
-
London, United Kingdom
- +1 more
Aug 17, 2021
Small Cell Lung Cancer Trial in New Haven (Combination immunotherapy with Ipilimumab and Nivolumab)
Active, not recruiting
- Small Cell Lung Cancer
- Combination immunotherapy with Ipilimumab and Nivolumab
-
New Haven, ConnecticutYale University, Yale Cancer Center
Apr 21, 2022
Novel Microfluidic Device to Purify Metastatic Lung Cancer
Recruiting
- Non Small Cell Lung Cancer
- Blood collection
-
Pierre-Bénite, FranceCentre Hospitalier Lyon Sud
Oct 11, 2021
Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)
Active, not recruiting
- Breast Adenocarcinoma
- +9 more
- Entinostat
- +4 more
-
Duarte, California
- +4 more
Jul 16, 2022
Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)
Active, not recruiting
- Advanced Malignant Neoplasm
- +38 more
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Sarcoma Trial in Houston (Autologous HER2-specific T cells, Fludarabine, Cyclophosphamide)
Active, not recruiting
- Sarcoma
- Autologous HER2-specific T cells
- +3 more
-
Houston, Texas
- +1 more
Nov 21, 2022
Lymphoma, B-Cell Trial in Beijing (ET190L1 ARTEMIS™ T cells)
Completed
- Lymphoma, B-Cell
- ET190L1 ARTEMIS™ T cells
-
Beijing, ChinaPeking University Cancer Hospital
Mar 12, 2021
Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)
Terminated
- Hodgkin Disease
- Hodgkin Lymphoma
- Auto stem cell transplant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021
Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow
Active, not recruiting
- Chronic Myeloid Leukemia
- +2 more
- Imatinib
- +3 more
-
Moscow, Russian FederationNational Research Center for Hematology
Oct 1, 2020
NSCLC Trial in Beijing, Tianjin (TQB2450 injection, docetaxel injection matching , AL2846 capsules, TQB2450 matching , docetaxel
Recruiting
- Non-small Cell Lung Cancer
- TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules
- TQB2450 matching placebo, docetaxel injection, AL2846 matching placebo
-
Beijing, Beijing, China
- +2 more
Jun 19, 2023
Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT
Recruiting
- Lung Cancer Stage III
- Lung Cancer Stage IV
-
Brest, FranceChu Brest
Aug 16, 2023
Sickle Cell Trait Trial in Saint Louis (Exercise)
Recruiting
- Sickle Cell Trait
- Exercise
-
Saint Louis, MissouriSaint Louis University
Jan 11, 2022
Respiratory Infections in Old Age, Bacteremia Trial in France, Italy, Spain (Geriatric assessment tools)
Recruiting
- Respiratory Infections in Old Age
- Bacteremia
- Geriatric assessment tools
-
Amiens, France
- +21 more
May 24, 2022
Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem
Active, not recruiting
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
Advanced Renal Cell Carcinoma Trial (QL1706 Plus Lenvatinib)
Not yet recruiting
- Advanced Renal Cell Carcinoma
- QL1706 Plus Lenvatinib
- (no location specified)
Feb 21, 2022
Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Non Small Cell Lung Cancer Trial in Lyon (Cicaplast Balm B5, Dexeryl)
Completed
- Head and Neck Squamous Cell Carcinoma
- +3 more
- Cicaplast Balm B5
- Dexeryl
-
Lyon, Rhône, FranceCentre Léon Bérard
Jul 8, 2021
COVID-19 Trial (Text-Messaging (TM), Patient Navigation (PN))
Not yet recruiting
- COVID-19
- Text-Messaging (TM)
- Patient Navigation (PN)
- (no location specified)
Sep 7, 2022
go Back Into Records and Observe How People With Metastatic
Not yet recruiting
- Carcinoma, Renal Cell
- Clear-cell Metastatic Renal Cell Carcinoma
-
Istanbul, TurkeyPfizer
Feb 15, 2023
Multiple Myeloma, Renal Failure Trial in Worldwide (Data collection)
Active, not recruiting
- Multiple Myeloma
- Renal Failure
- Data collection
-
Alger, Algeria
- +32 more
Feb 7, 2022
Endothelial Cell Gene Networks of CVD
Withdrawn
- Coronary Heart Disease
- isolation of endothelial cells precursors in blood
-
Boston, MassachusettsTufts Medical Center - Cardiovascular Clinic
Jul 27, 2021
Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)
Completed
- Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
-
Bordeaux, Aquitaine, France
- +11 more
Dec 6, 2020